Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BWAY NASDAQ:PAVM NASDAQ:PDEX NASDAQ:SNWV On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBWAYBrainsway$15.47-3.1%$13.78$7.84▼$17.00$292.41M1.3472,079 shs58,196 shsPAVMPAVmed$0.44+5.5%$0.49$0.30▼$1.76$9.65M1.09265,969 shs216,471 shsPDEXPro-Dex$34.36-1.2%$43.79$26.28▼$70.26$112.01M-0.0437,311 shs46,804 shsSNWVSanuwave Health$34.88-0.6%$37.89$5.63▼$46.58$298.92M1.3939,208 shs61,277 shsReduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBWAYBrainsway0.00%-1.90%+1.78%+34.64%+90.99%PAVMPAVmed0.00%+4.74%-6.10%-28.23%-72.67%PDEXPro-Dex0.00%+3.90%-25.35%-17.84%+28.64%SNWVSanuwave Health0.00%-5.68%-22.49%+3.90%+3,487,999,900.00%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBWAYBrainsway$15.47-3.1%$13.78$7.84▼$17.00$292.41M1.3472,079 shs58,196 shsPAVMPAVmed$0.44+5.5%$0.49$0.30▼$1.76$9.65M1.09265,969 shs216,471 shsPDEXPro-Dex$34.36-1.2%$43.79$26.28▼$70.26$112.01M-0.0437,311 shs46,804 shsSNWVSanuwave Health$34.88-0.6%$37.89$5.63▼$46.58$298.92M1.3939,208 shs61,277 shsReduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBWAYBrainsway0.00%-1.90%+1.78%+34.64%+90.99%PAVMPAVmed0.00%+4.74%-6.10%-28.23%-72.67%PDEXPro-Dex0.00%+3.90%-25.35%-17.84%+28.64%SNWVSanuwave Health0.00%-5.68%-22.49%+3.90%+3,487,999,900.00%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBWAYBrainsway 3.00Buy$18.0016.35% UpsidePAVMPAVmed 3.00Buy$19.004,218.18% UpsidePDEXPro-Dex 3.00Buy$56.0062.98% UpsideSNWVSanuwave Health 3.33Buy$55.0057.68% UpsideCurrent Analyst Ratings BreakdownLatest PAVM, SNWV, BWAY, and PDEX Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails9/3/2025SNWVSanuwave HealthNorthland CapmkSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong-Buy9/3/2025SNWVSanuwave HealthNorthland SecuritiesSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageOutperform$55.008/25/2025BWAYBrainswayHC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$17.008/22/2025SNWVSanuwave HealthRoth CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$54.00 ➝ $55.008/14/2025BWAYBrainswayHC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$16.00 ➝ $17.008/14/2025BWAYBrainswayNorthland SecuritiesSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOutperform$15.00 ➝ $19.007/29/2025SNWVSanuwave HealthRoth CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$49.00(Data available from 9/22/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBWAYBrainsway$46.08M6.35$0.25 per share62.04$3.31 per share4.67PAVMPAVmed$1.02M9.46N/AN/A($0.92) per share-0.48PDEXPro-Dex$66.59M1.68$3.14 per share10.96$11.23 per share3.06SNWVSanuwave Health$32.63M9.16N/AN/A($1.49) per share-23.41Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBWAYBrainsway$2.92M$0.2659.5096.69N/A11.60%8.97%5.65%11/11/2025 (Estimated)PAVMPAVmed$39.79M$1.160.38N/AN/A7,144.80%N/A-20.96%11/12/2025 (Estimated)PDEXPro-Dex$8.98M$2.7012.7316.68N/A13.48%26.67%14.95%10/30/2025 (Estimated)SNWVSanuwave Health-$31.37M-$8.25N/A∞N/A-97.03%N/A-135.15%N/ALatest PAVM, SNWV, BWAY, and PDEX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails9/4/2025Q4 2025PDEXPro-Dex$0.47$0.36-$0.11$0.36$17.90 million$17.49 million8/13/2025Q2 2025BWAYBrainsway$0.07$0.10+$0.03$0.10$12.34 million$12.63 million8/8/2025Q2 2025SNWVSanuwave Health-$0.09$0.01+$0.10$0.01$10.14 million$10.16 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBWAYBrainswayN/AN/AN/AN/AN/APAVMPAVmedN/AN/AN/AN/AN/APDEXPro-DexN/AN/AN/AN/AN/ASNWVSanuwave HealthN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBWAYBrainswayN/A3.513.34PAVMPAVmedN/A0.520.52PDEXPro-Dex0.253.231.71SNWVSanuwave HealthN/A0.430.31Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBWAYBrainsway30.11%PAVMPAVmed19.93%PDEXPro-Dex15.28%SNWVSanuwave Health42.53%Insider OwnershipCompanyInsider OwnershipBWAYBrainsway19.00%PAVMPAVmed7.30%PDEXPro-Dex47.50%SNWVSanuwave Health14.90%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBWAYBrainsway12018.90 million15.32 millionNot OptionablePAVMPAVmed9021.93 million20.33 millionOptionablePDEXPro-Dex1403.26 million1.71 millionNot OptionableSNWVSanuwave Health408.57 million7.29 millionN/APAVM, SNWV, BWAY, and PDEX HeadlinesRecent News About These CompaniesSanuwave Health (NASDAQ:SNWV) Cut to "Hold" at Wall Street ZenSeptember 21 at 2:49 AM | americanbankingnews.comSanuwave Health (NASDAQ:SNWV) Cut to Hold at Wall Street ZenSeptember 20 at 2:15 AM | marketbeat.comSanuwave: A Long-Term Compounder In Its Early StagesSeptember 15, 2025 | seekingalpha.comSanuwave Health (NASDAQ:SNWV) Downgraded to Buy Rating by Wall Street ZenSeptember 9, 2025 | marketbeat.comSanuwave Health (NASDAQ:SNWV) Stock Rating Lowered by Wall Street ZenSeptember 9, 2025 | marketbeat.comNorthland Capmk Forecasts Sanuwave Health Q3 EarningsSeptember 7, 2025 | marketbeat.comSanuwave Health (NASDAQ:SNWV) Upgraded to "Strong-Buy" at Northland CapmkSeptember 6, 2025 | marketbeat.comSanuwave Health (NASDAQ:SNWV) Now Covered by Northland SecuritiesSeptember 5, 2025 | marketbeat.comAWM Investment Company Inc. Invests $18.15 Million in Sanuwave Health Inc. $SNWVSeptember 5, 2025 | marketbeat.comSolas Capital Management LLC Invests $20.66 Million in Sanuwave Health Inc. $SNWVSeptember 2, 2025 | marketbeat.comSanuwave Health (NASDAQ:SNWV) Rating Increased to Strong-Buy at Wall Street ZenSeptember 1, 2025 | marketbeat.comSANUWAVE Health, Inc. (SNWV) Q2 2025 Earnings Call TranscriptAugust 8, 2025 | seekingalpha.comSanuwave (SNWV) Q2 Revenue Jumps 42%August 8, 2025 | fool.comSanuwave Announces Q2 FY2025 Financial ResultsAugust 8, 2025 | globenewswire.comSanuwave Will Host a Conference Call on August 8, 2025 at 8:30 AM (ET) to Present Q2 2025 Financial ResultsAugust 4, 2025 | globenewswire.comSanuwave Health to Present at Canaccord Genuity Growth ConferenceJuly 22, 2025 | globenewswire.comSanuwave: High Growth Wound Care Tech Primed For A BreakoutJune 11, 2025 | seekingalpha.comSanuwave Health Appoints Industry Veteran Dustin Libby as Executive Vice President of Commercial OperationsJune 3, 2025 | globenewswire.comSANUWAVE Health, Inc. (SNWV): A Bull Case TheoryMay 29, 2025 | insidermonkey.comSanuwave Health Appoints Greg Bazar to Board of DirectorsMay 28, 2025 | globenewswire.comSanuwave Health Selected for Inclusion in Russell 2000® IndexMay 28, 2025 | globenewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimePAVM, SNWV, BWAY, and PDEX Company DescriptionsBrainsway NASDAQ:BWAY$15.47 -0.49 (-3.07%) Closing price 09/19/2025 04:00 PM EasternExtended Trading$15.84 +0.37 (+2.36%) As of 09/19/2025 05:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. BrainsWay Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.PAVmed NASDAQ:PAVM$0.44 +0.02 (+5.49%) Closing price 09/19/2025 04:00 PM EasternExtended Trading$0.44 0.00 (-0.91%) As of 07:12 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.PAVmed Inc. focuses on acquiring, developing, and commercializing novel products that target unmet needs in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; EsoCheck Esophageal Cell Collection Device, which consists of diagnostic test that serves as a testing tool for preventing esophageal adenocarcinoma deaths, through early detection of esophageal precancer in at-risk gastroesophageal reflux disease, including chronic heartburn and acid reflux or simply reflux in patients; and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay performed on surface esophageal cells collected with EsoCheck. Its product pipeline also comprises EsoCure EsoCure Esophageal Ablation Device for treating dysplastic BE; PortIO, an implantable intraosseous vascular access device; and Veris cancer care platform. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is headquartered in New York, New York.Pro-Dex NASDAQ:PDEX$34.36 -0.40 (-1.15%) Closing price 09/19/2025 04:00 PM EasternExtended Trading$34.32 -0.04 (-0.12%) As of 09/19/2025 05:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company's products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations. Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California.Sanuwave Health NASDAQ:SNWV$34.88 -0.21 (-0.60%) As of 09/19/2025 04:00 PM EasternSANUWAVE Health, Inc., a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States and internationally. Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, and musculoskeletal and vascular structures. The company's lead regenerative product is the dermaPACE device for treating diabetic foot ulcers. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, which helps to restore the body's normal healing processes and regeneration. The company also focuses on applying its Pulsed Acoustic Cellular Expression technology in wound healing, orthopedic, plastic/cosmetic, and cardiac conditions. In addition, it offers UltraMIST, non-contact and non-thermal ultrasound therapy device used to treat diabetic foot ulcers, pressure ulcers, venous leg ulcers, deep tissue pressure injuries, and surgical wounds; and orthoPACE system to treat tendinopathies and acute and nonunion fractures. The company was founded in 2005 and is headquartered in Suwanee, Georgia. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas GameStop Partying Like It’s 2021: What’s Behind Its 2025 Rebound? Hims & Hers Stock Pushes to Highs on Healthcare Rate Cut Frenzy FedEx Delivers Good News: The Bottom Is in for This Stock Tesla: 2 Reasons to Love Musk's $1B Buy, 1 Reason to Be Bearish Berkshire-Backed Lennar Slides After Weak Q3 Earnings Azure Leads While AI Excitement Fuels Microsoft Stock Caterpillar Stock Hits All-Time High—Is There More Room to Run? The Fed Cut Rates: What Now for the S&P 500 and Equity Markets? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
